Research feed

Latest Diabetes Research

Recently added diabetes research, organized by intervention and outcome.

Sorted by when Dediabetes added each study.

Last updated: Sep 12, 20261,338 studies indexed

September 2026

Added to Dediabetes Sep 10, 2026RCTs

Atorvastatin may slow beta cell decline in type 1 diabetes

This study investigated the effects of atorvastatin on beta cell function in type 1 diabetes, finding that atorvastatin may enhance stimulated C-peptide secretion in certain subgroups.

Interventions
Atorvastatin
Outcomes
C-peptideCorrelation of baseline CRP levels with C-peptide outcome
Added to Dediabetes Sep 9, 2026RCTs

Technology-enhanced program improves cardiometabolic status in young adults with diabetes

The PRISM study evaluated the effectiveness of the JADE-PRISM intervention compared to usual care in diabetes management, finding significant improvements in treatment target attainment and emotional distress.

Interventions
Joint Asia Diabetes Evaluation (JADE)-PRISMUsual care
Outcomes
Attainment of three or more treatment targetsBeta-cell functionExploratory patient-reported measures+1 more
Added to Dediabetes Sep 9, 2026RCTs

Telephone support for lifestyle changes shows no reduction in diabetes incidence

This study evaluated a postpartum telephone-based lifestyle intervention for women at high risk of diabetes after gestational diabetes mellitus. The findings indicated no significant reduction in diabetes incidence or weight gain.

Interventions
Normal carePostpartum telephone support for lifestyle changes
Outcomes
Discrepancy between clinically measured weight and self-reported weight associated with BMIGestational diabetes mellitus incidence
Added to Dediabetes Sep 12, 2026RCTs

Liraglutide improves glycaemic control in type 2 diabetes

This study evaluated the effects of liraglutide on glycaemic control in patients with Type 2 diabetes inadequately managed with SGLT2 inhibitors, finding significant improvements in HbA1c levels.

Interventions
Liraglutide
Outcomes
Body weightHbA1cProportion achieving HbA1c <7.0%+1 more
Added to Dediabetes Sep 10, 2026RCTs

Perceived exertion may guide exercise intensity in type 1 diabetes

This study explored perceived exertion and enjoyment during exercise in adults with type 1 diabetes, finding higher exertion ratings after strength training compared to aerobic training.

Interventions
High-intensity interval exerciseStrength session AStrength session B
Outcomes
Blood glucoseImprovement in enjoyment of pregnancyRatings of perceived exertion (RPE)
Added to Dediabetes Sep 10, 2026RCTs

High-Dose Oral Insulin Shows No Benefit in Type 1 Diabetes Progression

This study evaluated the effects of high-dose oral insulin in children with Stage 1 Type 1 Diabetes. It found no significant difference in progression to dysglycemia or immune response compared to placebo.

Interventions
Oral insulin
Outcomes
Glycemic control comparison to commercial AID systemsMean arterial pressure reduction
Added to Dediabetes Sep 10, 2026RCTs

Omega-3 supplementation improves glycemic control in type 2 diabetes

This study investigated the effects of omega-3 fatty acids coadministered with glimepiride on glycemic control in patients with type 2 diabetes mellitus (T2DM). It found significant reductions in fasting plasma glucose and glycated hemoglobin levels.

Interventions
1 g omega-3 fatty acids dailyPlacebo with glimepiride
Outcomes
Atherogenic Index of Plasma IncreaseChange in serum irisin levelFasting Plasma Glucose (FPG)+6 more
Added to Dediabetes Sep 9, 2026RCTs

Diabetes and PCI Linked to Higher 10-Year Mortality

This study examined long-term outcomes in patients with left main coronary artery disease and diabetes undergoing PCI, revealing significant mortality differences based on diabetes treatment.

Interventions
Percutaneous coronary intervention (PCI)
Outcomes
All-cause mortalityCardiac deathCoronary artery bypass graft surgery+4 more

Latest Evidence

Never miss new evidence

Build your workspace to keep track of the latest diabetes research.